Search hospitals > Wisconsin > Milwaukee
Aurora Sinai Medical Center
Claim this profileMilwaukee, Wisconsin 53233
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Ovarian Cancer
223 reported clinical trials
21 medical researchers
Summary
Aurora Sinai Medical Center is a medical facility located in Milwaukee, Wisconsin. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Non-Small Cell Lung Cancer, Ovarian Cancer and other specialties. Aurora Sinai Medical Center is involved with conducting 223 clinical trials across 319 conditions. There are 21 research doctors associated with this hospital, such as Thomas J. Saphner, Rubina Qamar, Antony Ruggeri, and Sigrun Hallmeyer, MD.Area of expertise
1Breast Cancer
Global LeaderHER2 negative
ER positive
HER2 positive
2Lung Cancer
Global LeaderStage IV
Stage II
Stage III
Top PIs
Thomas J. SaphnerAurora Saint Luke's Medical Center2 years of reported clinical research
Studies Breast Cancer
Studies Cancer
30 reported clinical trials
68 drugs studied
Rubina QamarAurora Saint Luke's Medical Center5 years of reported clinical research
Studies Breast Cancer
Studies Lung Cancer
24 reported clinical trials
68 drugs studied
Antony RuggeriAurora Cancer Care-Milwaukee West5 years of reported clinical research
Studies Pancreatic Cancer
Studies Colon Cancer
14 reported clinical trials
57 drugs studied
Sigrun Hallmeyer, MDAdvocate Lutheran General Hospital2 years of reported clinical research
Studies Breast Cancer
Studies Cancer
13 reported clinical trials
23 drugs studied
Clinical Trials running at Aurora Sinai Medical Center
Lung Cancer
Breast Cancer
Bladder Cancer
Ovarian Cancer
Cancer
Prostate Cancer
Non-Small Cell Lung Cancer
Esophageal cancer
Breast cancer
Kidney Cancer
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Chemotherapy + Immunotherapy vs. Immunotherapy
for Advanced Lung Cancer
This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab and chemotherapy may help stabilize lung cancer.
Recruiting2 awards Phase 3
High-Dose Radiation + Chemotherapy and Immunotherapy
for Non-Small Cell Lung Cancer
This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Recruiting2 awards Phase 314 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Aurora Sinai Medical Center?
Aurora Sinai Medical Center is a medical facility located in Milwaukee, Wisconsin. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Non-Small Cell Lung Cancer, Ovarian Cancer and other specialties. Aurora Sinai Medical Center is involved with conducting 223 clinical trials across 319 conditions. There are 21 research doctors associated with this hospital, such as Thomas J. Saphner, Rubina Qamar, Antony Ruggeri, and Sigrun Hallmeyer, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.